Stockscreener 앱 받기
96.73
0.99%
-0.97
시장 영업 전:
97.35
0.62
+0.64%
전일 마감가:
$97.70
열려 있는:
$97.47
하루 거래량:
618.70K
Relative Volume:
0.67
시가총액:
$5.53B
수익:
$360.35M
순이익/손실:
$-149.57M
주가수익비율:
-32.68
EPS:
-2.96
순현금흐름:
$-81.27M
1주 성능:
-7.16%
1개월 성능:
-3.41%
6개월 성능:
-39.29%
1년 성능:
-19.88%
1일 변동 폭
$96.69
$98.64
1주일 범위
$96.69
$104.72
52주 변동 폭
$77.10
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
명칭
Glaukos Corporation
전화
949-367-9600
주소
1 GLAUKOS WAY, ALISO VIEJO, CA
GKOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
96.73 | 5.95B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-05-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-12-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-11-28 | 개시 | Truist | Buy |
| 2023-11-08 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-04 | 개시 | Needham | Buy |
| 2022-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2022-02-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-11-03 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
| 2020-12-09 | 개시 | Oppenheimer | Perform |
| 2020-11-17 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-06-15 | 개시 | Jefferies | Hold |
| 2020-03-05 | 개시 | Citigroup | Sell |
| 2020-02-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-01-06 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-12-12 | 다운그레이드 | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | 개시 | BTIG Research | Neutral |
| 2018-08-30 | 개시 | Berenberg | Hold |
| 2018-08-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-03 | 재확인 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-04-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-01 | 재확인 | Cantor Fitzgerald | Buy |
| 2017-03-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2016-10-27 | 개시 | Wells Fargo | Outperform |
모두보기
Glaukos Corporation 주식(GKOS)의 최신 뉴스
Glaukos Corporation Stock Analysis and ForecastExceptional market positioning - jammulinksnews.com
What analysts say about Glaukos Corporation stockRapid wealth creation - jammulinksnews.com
What drives Glaukos Corporation stock priceFree Daily Trading Room Entry - Autocar Professional
Is Glaukos Corporation a good long term investmentFree Stock Market Trend Analysis - jammulinksnews.com
What analysts say about Glaukos Corporation stock outlookFree Insider Trading Tips - beatles.ru
Midday Stock Roundup: loanDepot Shoots Up 16% - Orange County Business Journal
September 19th Options Now Available For Glaukos (GKOS) - Nasdaq
BTIG Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $117 - 富途牛牛
(GKOS) Investment Report - news.stocktradersdaily.com
Breakeven On The Horizon For Glaukos Corporation (NYSE:GKOS) - simplywall.st
BTIG Increases Glaukos (GKOS) Price Target Ahead of Q2 Results | - GuruFocus
Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30 - BioSpace
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks - Yahoo Finance
Glaukos to Release Second Quarter 2025 Financial Results after M - GuruFocus
Press Release: Glaukos to Release Second Quarter 2025 Financial Results After Market Close on July 30 - 富途牛牛
Glaukos Prepares for New Product Launches - Orange County Business Journal
Glaukos Corporation(NYSE: GKOS) added to Russell 2000 Defensive Index - MarketScreener
Glaukos gains EU certification for iStent infinite and other MIGS devices - Yahoo Finance
Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies - BioSpace
Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies | GKOS Stock News - GuruFocus
Trend Tracker for (GKOS) - news.stocktradersdaily.com
Glaukos receives EU certification for glaucoma surgery devices - Investing.com
Glaukos Corporation: Delivering Consistent Growth (NYSE:GKOS) - Seeking Alpha
Glaukos Trades Higher Than Medical Peers NYSE Composite - Kalkine Media
What Makes Glaukos (GKOS) a New Buy Stock - Yahoo Finance
Why We're Not Concerned About Glaukos Corporation's (NYSE:GKOS) Share Price - simplywall.st
Trading (GKOS) With Integrated Risk Controls - news.stocktradersdaily.com
Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks - Investing.com Canada
Glaukos Corp (GKOS) Shares Up 6.05% on Jun 11 - GuruFocus
Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect? - sharewise
Here’s Why Glaukos (GKOS) Shares Traded Lower in Q1 - Insider Monkey
Stifel maintains buy rating on Glaukos stock, $115 target unchanged By Investing.com - Investing.com India
Glaukos at Jefferies Conference: Eyeing Interventional Success By Investing.com - Investing.com South Africa
Glaukos at Jefferies Conference: Eyeing Interventional Success - Investing.com
Stifel maintains buy rating on Glaukos stock, $115 target unchanged - Investing.com
Glaukos at William Blair Conference: Eyeing Innovative Growth By Investing.com - Investing.com South Africa
glaukos corp reports annual meeting voting results By Investing.com - Investing.com South Africa
glaukos corp reports annual meeting voting results - Investing.com
Glaukos Stockholders Approve Key Proposals at Annual Meeting - TipRanks
Glaukos at William Blair Conference: Eyeing Innovative Growth - Investing.com Australia
Glaukos Corporation (GKOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.17%
자본화:
|
볼륨(24시간):